Professional Documents
Culture Documents
Labor and Delivery Guidance For COVID-19
Labor and Delivery Guidance For COVID-19
FIGURE 1
Flowchart for triaging patients who call into labor and delivery. COVID-19, coronavirus disease 2019; PPE,
personal protective equipment
Boelig et al. Labor and delivery guidance for COVID-19. AJOG MFM 2020.
symptoms of COVID-19 has already labor, rupture of membranes, vaginal so on. They should appropriate desig-
been described.6 Inpatient management bleeding), should be evaluated in an L&D nated rooms and operating rooms
of pregnant women is similar to outpa- area dedicated to patients with COVID- (ORs). For women with planned ad-
tient recommendations with regard to 19. Providers should follow up on test missions for induction of labor or ce-
minimizing and eliminating all unnec- results and notify the team of any positive sarean section, consider screening each
essary contact of the patient with the test results. individual and her birthing partner by
hospital or birth center to optimize so- Labor presents a unique scenario in a telephone call the day before
cial distancing. In most cases, necessary the COVID-19 pandemic, as all hospital admission.
patient-provider contacts should be admissions are anticipated and the
made through telehealth or remotely, timing of many admissions to the hos- Section 2: Screening of Patients
unless the patient describes an urgent pital is planned. In anticipation of hos- Coming to L&D Triage
problem.6 pital admission and to limit the risk of When women arrive at L&D, a desig-
Phone calls to L&D should be triaged exposure, women should be instructed nated staff member at the front of the
as shown in Figure 1. Patients calling with to discontinue work or begin working unit (eg, patient access coordinator, unit
symptoms of COVID-19 or influenza or from home a minimum of 2 weeks coordinator) should verbally screen each
with direct contacts who have no urgent before the anticipated date of delivery individual for upper respiratory tract
obstetric issues should be referred for and to practice strict social isolation infection (URTI) symptoms. Any
testing outside of the hospital as per local during this time. For most women, this woman reporting fever, cough, or res-
protocols, for example, through outside should be initiated at about 37 weeks. piratory symptoms should be given a
drive-through testing centers. Women In addition, L&D units should prepare surgical mask and evaluated by a regis-
without urgent obstetric issues awaiting simulations of the COVID-19 tered nurse or obstetric care provider.
results should stay at home to self-isolate. pandemic, including for donning per- The recommended flow is presented in
Those with urgent obstetric issues (eg, sonal protective equipment (PPE) and Figure 2. All birthing partners should be
FIGURE 2
Suggested flow for screening patients presenting to labor and delivery triage. COVID-19, coronavirus disease
2019; PPE, personal protective equipment
Boelig et al. Labor and delivery guidance for COVID-19. AJOG MFM 2020.
verbally screened; if they screen positive, by the Centers for Disease Control nebulized medications. Second
they should not be permitted to L&D and Prevention (CDC) until COVID- stage of labor is likely high risk for
and should be directed to appropriate 19 has been ruled out. aerosolization, and N-95 mask
testing or medical care as indicated. Current CDC recommendations should be used.12,13 The CDC has
Where testing capacity allows, universal include the use of a surgical mask, indicated that N-95 masks are as
testing of all labor admissions should be protective eyewear, gown, and gloves. effective as powered air-purifying
performed due to the likely high rate of An N-95 mask should be utilized, if respirators and should be used for
asymptomatic COVID-19epositive pa- available, for any women with protection in the event of short-
tients.10 If universal testing is not confirmed or suspected COVID-19.11 term exposure.11
possible, a screening algorithm as in Aerosolization should in general be Practice vigilant hand hygiene.
Figure 2 should be followed. avoided because it increases the
spread of the virus. If absolutely Management of patients who screen positive.
Important considerations in the care of necessary, N-95 masks should be
patients who screen positive used in setting of aerosolization, Acute complaint requiring evalua-
Appropriate isolation and sanitation. including if patient is on bilevel tion (severe symptoms, labor
positive airway pressure, has a tra- complaint, etc.):
All healthcare providers should be cheostomy, requires high-flow nasal o A special room should be reserved
following the PPE recommendations cannula O2, or when administering as space allows for patients who
screen positive (eg, URTI symp- Visitor policy monitoring and observation for a
toms, fever), for both triage and Given the significant risk of COVID- longer period than what might typi-
labor. 19 transmission between patients, cally occur, and then transferring her
Scheduled CD or induction of labor: families, and healthcare providers, directly to the antepartum unit rather
o Ideally, this should be determined there should be strict restrictions on than moving her to an L&D room as an
when screening the patient by visitor policy. intermediary stop.
phone the day before admission to
avoid travel to the hospital (as L&D Pre-CD laboratory tests
suggested above). o Visitation should be limited to 1 To limit multiple visits to a healthcare
o Evaluation should be conducted to support person, in-person. Pref- setting, women should undergo routine
determine if rescheduling in 2e3 erence is for support through preoperative laboratory tests (eg, com-
days is feasible to allow for results video, if patient agrees. All in- plete blood cell count, type and screen)
of COVID-19 testing if necessary. person support people should be on the day of their CD.
o For COVID-19epositive patients screened as per Section 2. The
with mild or moderate symptoms support person should be easily Section 4: Intrapartum Care
not requiring immediate care, it is identifiable by L&D staff; one Inductions of labor
important to recognize that the suggestion would be to provide Inductions of labor with medical in-
severity of disease peaks often in them with a special colored wrist dications in asymptomatic women
the second week; therefore, plan- band that must be worn at all should not be postponed or rescheduled.
ning delivery before that time is times. Switching of visitors will This includes inductions at 39 week of
optimal. not be permitted. Given the pregnancy, after patient counseling.19
public health emergency, no However, in cases of extreme healthcare
Section 3. General Changes to additional in-person support system burden (see Section 2), it may be
Routine L&D Work Flow people should be allowed, appropriate to consider postponing or
Respiratory precautions and PPE including doulas. rescheduling the induction. This
Given the risk of asymptomatic carriers Antepartum and postpartum recommendation will vary depending on
and transmission,10 it should be the goal o There should be a designated sup- the current state of the COVID-19
of every unit that every patient wear a port person for the entire admis- pandemic. For example, in a region
surgical mask and that every provider sion. This should be the same with early COVID-19 emergence, it may
should have a surgical mask for each pa- designated person as for delivery. be prudent to proceed with delivery
tient encounter.14,15 However, the ability Neonatal intensive care unit before high COVID-19 burden in the
to execute this recommendation is obvi- o Parents may visit in the neonatal hospital. For sites with an existing high
ously limited by supply. For any patients ICU one at a time. COVID-19 burden, an additional stay of
with respiratory symptoms, full droplet No children younger than 16e18 1e2 days in the hospital, occupying a
precautions should be utilized, including years will be permitted at any time. hospital bed, for an induction of labor
the use of gloves, gown, and surgical mask Additional visitors for end-of-life may not be possible. Other site-specific
with a face shield. N95 mask should be situations may be considered and and COVID-19especific considerations
worn in addition to droplet precaution evaluated on a case-by-case basis. may include options such as beginning
PPE for any patients with suspected or the induction process at home to limit
confirmed COVID, and for any patient, Visitation may be further restricted at in-hospital time (eg, outpatient Foley
regardless of respiratory symptoms, during the discretion of unit leadership and as bulb cervical ripening). Induction can
indispensable aerosol-generating pro- the outbreak evolves. still be conducted as usual, with a com-
cedures, including the second stage of bination of 60- to 80-mL single-balloon
labor.11,16 As much as possible, oxygen Patient admissions and location Foley for 12 hours and either oral 25-
should not be given aerosolized. In In general, all efforts should be made to mcg misoprostol initially, followed by
addition, hand hygiene with alcohol- limit the movement of women from one 25 mcg every 2e4 hours, or 50 mcg every
based handrub after every patient con- care area to another (eg, triage room to 4e6 hours (if no more than 3 contrac-
tact and appropriate donning and doffing antepartum room to L&D room). Ad- tions per 10 minutes or previous uterine
of PPE are critical.11e17 Finally, rooms missions for delivery should remain on surgery), or oxytocin infusion.20
that are exposed need to be wiped down L&D; consider admitting stable admis- Outpatient Foley cervical ripening can
as respiratory viruses may spread from sions for antepartum monitoring be considered for low-risk women, to
surface contact.18 These aggressive mea- directly to the antepartum unit. For minimize contacts. CD should not be
sures can help limit transmission in pro- example, consider holding a woman performed before 15 hours of oxytocin
viders in a healthcare setting. Table 1 with preterm prelabor rupture of and amniotomy if feasible, and ideally
summarizes our recommendations. membranes in triage for continuous after 18e24 hours of oxytocin.20
TABLE 1
Suggested PPE based on clinical situation
Droplet PPE (gown,
gloves, surgical
Individual and clinical situation Surgical mask mask/face shield) N-95 mask
Patient (with or without respiratory symptoms) X
Provider during routine patient encounter X
Provider during contact with patient with suspected or X X
confirmed COVID-19
Provider caring for patient during aerosol-generating X X
procedure including second stage of labor
COVID, coronavirus disease 2019; PPE, personal protective equipment; URTI, upper respiratory tract infection.
Boelig et al. Labor and delivery guidance for COVID-19. AJOG MFM 2020.
First stage labor; higher doses of oxytocin can be involves respiratory contamination.
General guidance. Management of the considered; early intervention with Eliminating nitrous oxide use
first stage should not be altered, unless oxytocin and amniotomy for the pre- during COVID-19 pandemic is
specified below. Intrapartum antibiotic vention and treatment of dysfunctional recommended.24
prophylaxis is recommended for group or slow labor is recommended; CD for
B Streptococcusepositive patients, im- arrest in the first stage of labor should Second stage
mersion in water in the first stage of not be performed unless labor has Management during the second stage of
labor can be considered, oral restriction arrested for a minimum of 4 hours with labor should not be altered, unless
of fluid or solid food in the first stage of adequate uterine activity, or 6 hours specified as in Section 6. See general and
labor is not recommended, and oral with inadequate uterine activity in a specific guidance for first stage, much of
administration of water and clear fluids woman with rupture of membranes, which applies to the second stage as well.
can be encouraged as tolerated in labor. adequate oxytocin, and 6-cm dilated Pushing should not be delayed because it
In case of oral restriction, intravenous cervix.20 prolongs time to delivery and increases
fluid containing dextrose at a rate of 125 chorioamnionitis and postpartum
mL/h; given the significant risk of Oxygen therapy. Although oxygen via hemorrhage.25,26 Perineal massage27 and
asymptomatic carriers especially in the nasal cannula is not considered an warm packs28 are each associated with
absence of universal testing, there aerosol-generating procedure, the fact decrease in third and fourth degree
should be conscious use of fluids. Up- that nasal cannula or face mask are in lacerations.
right positions in the first stage of labor contact with maternal respiratory tract
are recommended in women without and secretions makes handling of such Third stage
regional anesthesia, women with equipment (taking on, taking off, or There are concerns regarding limited
regional anesthesia in the first stage can adjusting) can lead to a greater possi- resources for blood transfusion because
take whatever position they find most bility of contamination or exposure be- of inability to run blood drives. Given
comfortable, and walking should be tween patient and provider. A recent this situation, all care should be taken to
recommended in the first stage of labor meta-analysis has demonstrated that reduce the need for blood transfusion,
in women without regional anesthesia, intrapartum oxygen has no fetal benefit including optimizing antenatal hemo-
but in the delivery room. Women with and may cause harm.21,22 In the current globin before delivery. In addition to
regional anesthesia can walk or not walk scenario wherein reducing the risk of standard oxytocin, consideration should
in the first stage of labor; continuous COVID-19 spread among healthcare be made for prophylactic tranexamic
bladder catheterization cannot be rec- providers and patient is paramount, acid and misoprostol (400 mcg
ommended in labor, and routine use of there is even more reason to not utilize buccally).29 The use of cell-salvage dur-
peanut ball cannot be recommended in oxygen therapy for fetal resuscitation. ing CD should be considered after
labor because it has not been shown to Given the likely high rate of asymp- stratification of risk for postpartum
be beneficial and may be a way to tomatic carriers,23 this principle applies hemorrhage and institutional capabil-
transmit infection. Oxytocin augmen- regardless of patient’s COVID-19 status. ities. If blood transfusion is indicated
tation is recommended to shorten the and hemorrhage is not ongoing, begin
time to delivery for women making slow Nitrous oxide. The use of nitrous oxide with transfusion of 1 unit rather than the
progress in the first stage of spontaneous involves risk of aerosolization and typical 2 units of packed red blood cells,
then reassess the clinical need for the Encourage either long-acting revers- morbidity.35,36 Generally, steroid use
second unit. ible contraceptive placement or evaluated in these studies is higher than
Some have advocated for avoiding Depo-Provera injection before a 2-day course of steroids; however,
delayed cord clamping, even if vertical discharge for patients planning to use given the association between steroids
transmission has not been confirmed at these to eliminate need for additional and worsening morbidity of viral
the time of the submission of this in-person postpartum visits. pneumonia and specifically COVID-19,
manuscript. judicial use of steroids for fetal lung
Section 6: Care for the Suspected or maturity is recommended. It should be
Anesthesia considerations Confirmed COVID-19ePositive noted that the dose of steroids used for
The Society for Obstetric Anesthesia and Pregnant Patient in L&D fetal lung maturity are lower than the
Perinatology has published interim Obstetric medications systemic doses that have been used and
guidelines based on expert opinion. As Two commonly used medications in studied in the setting of COVID-19 and
with other COVID-19 guidelines, these obstetrics have been the source of study other respiratory conditions. Consider
are rapidly evolving.24 and controversy in the setting of Table 2 for steroid use for fetal lung
COVID-19 pandemic; nonsteroidal maturity balancing benefit by risk of
Early epidural should be used to anti-inflammatory drugs (NSAIDs), in delivery within the next 7 days, gesta-
minimize need for general anesthesia in particular indomethacin, are commonly tional age, and potential risk based on
the event of emergent cesarean section. used for tocolysis, and steroids, specif- maternal presentation. These recom-
COVID-19 is not a contraindication ically betamethasone or dexamethasone, mendations are supported by the
to neuraxial anesthesia. are used for fetal lung maturity. In WHO.5
Consider stopping nitrous oxide use addition, we will also address the use
due to potential risk of aerosolization. of magnesium, given the respiratory Magnesium sulfate. Magnesium sulfate is
morbidity of COVID-19 (Table 2). indicated for neuroprotection when de-
Section 5: Postpartum Care livery is anticipated <32 weeks or for
Women should be notified that they will Indomethacin. There were early reports eclampsia prophylaxis.37,38 There are no
be discharged in an expedited and safe postulating that NSAIDs may worsen the reported data regarding the impact of
fashion to limit the risk of infection to course of COVID-19. The virus binds to magnesium sulfate on COVID-19.
themselves, staff, and other patients. cells through the angiotensin-converting However, given the potential respira-
enzyme-2 (ACE-2) receptor; thus, it was tory complications with the use of
Expedited discharge planning postulated that NSAIDs, which increase magnesium sulfate, it should be used
All vaginal deliveries should have a ACE-2 expression, may result in wors- judiciously in case of severe respiratory
goal of discharge on postpartum day ening of the disease.30 However, this has symptoms with careful consideration of
1, or even the same day if possible for not been substantiated, and multiple both total fluids administered and kid-
selected women. organizations, including the World ney function. Magnesium sulfate may be
All CDs should have a goal of Health Organization (WHO) and the used as indicated in patients with mild or
discharge on postoperative day 2, with Food and Drug Administration (FDA) moderate symptoms.
consideration of postpartum day 1 have advocated there should not be a
discharge if meeting milestones. restriction on NSAID use.31 In the Laboratory value changes
Anticipated maternal discharge setting of tocolysis, nifedipine may be There are some changes noted with
should be discussed with pediatrics/ considered as an alternative given the COVID-19 that have important impli-
neonatology to determine timing of uncertainty regarding the impact of cations in care for the pregnant patients.
infant discharge. NSAIDs on COVID-19. These recom- Specifically, COVID-19 may be associ-
Home care with supplies for blood mendations may change as additional ated with transaminitis, elevated creati-
pressure follow-up will be critical to data emerge. nine, and thrombocytopenia.35 This is
expediting discharge of patients with an important consideration in a patient
a hypertensive disorder. Betamethasone/dexamethasone. The presenting with a hypertensive disorder
routine use of systemic corticosteroids in assessing whether she has severe fea-
Postpartum visit in case of a viral pneumonia has been tures of preeclampsia, hemolysis,
All postpartum visits, including associated with increased morbidity.32,33 elevated liver enzyme levels, and low
wound checks, should be arranged for One study showed delayed viral clear- platelet count syndrome, versus mani-
telehealth. Postpartum evaluation of ance with the use of corticosteroids in festation of COVID-19.
cesarean wound healing or mastitis those with Middle East respiratory syn-
concerns may be optimized through drome.34 Specifically with COVID-19, Intrapartum care
the use of photo upload options there is an association between steroid C Delivery timing
available in many electronic medical use and mortality, although these o COVID-19 severity peaks in the
record patient portal programs. studies do not control for baseline second week; thus, it may be
TABLE 2
Use of common medications in preterm labor management for pregnant patients with COVID-19
Gestational age <32 wk 32e34 wk 34e36 wk
Respiratory symptom Mild-moderate Mild-moderate
severity symptoms Severe symptoms Severe Any
Steroids for fetal Use Discuss risks and benefits Consider Avoid Avoid
maturity with multidisciplinary team
including ID, Pulmonary-Critical
Care, Neonatology
Indomethacin May consider if nifedipine Use nifedipine instead Use nifedipine Use nifedipine Not indicated
not an option instead instead
Magnesium sulfate Use Discuss risks and benefits with
(neuroprotection) multidisciplinary team including
ID, Pulmonary-Critical Care,
Neonatal-perinatal medicine
Severe signs or symptoms include need for respiratory support, hypoxia, etc.
COVID, coronavirus disease 2019; ID, Infectious Disease.
Boelig et al. Labor and delivery guidance for COVID-19. AJOG MFM 2020.
prudent to expedite delivery of consider having a team desig- o Appropriate planning, including
term COVID-19epositive pa- nated for confirmed or sus- simulation training, should be
tients with only mild symptoms. pected cases of COVID-19. done regarding planned, urgent,
C Mode of delivery C Medical care and emergent CD. Figure 3 pre-
o COVID-19 alone is not an indi- o Multidisciplinary care coordina- sents a suggested flow to consider.
cation for a CD. tion involving Maternal-Fetal Aspects to take into consideration
o Delivery mode should be dictated Medicine, Infectious Disease, include PPE placement in or near
by obstetric indications. Pulmonary/Critical care, Obstet- the OR to minimize time required
C Risk of vertical transmission ric anesthesia, and Neonatology for donning PPE in case of emer-
o There has been no documented o Consult Maternal Fetal Medicine gent CS, which providers will need
vertical transmission as of the regarding the use of steroids for additional PPE for direct patient
date of our submission based on fetal maturity, indomethacin, and contact, minimizing the number
limited case series39,40 of which magnesium sulfate (Table 2). of providers involved in direct
89% had cesarean sections. o Refer to intrapartum oxygen use patient contact, etc.
C Precautions for transmission guideline. Given the lack of fetal
prevention benefit, and risk of contamina- Postpartum care
o Designate nearby rooms, or a tion or transmission with the use C Although breastfeeding is still
section of the floor to be used for of an intranasal device, we do not encouraged (no evidence of
suspected and confirmed recommend the use of oxygen for COVID-19 transmission through
COVID-19epositive patients fetal resuscitation in any patient, breastmilk), given the risk of neonatal
o Respiratory precautions suspected case of COVID-19 or morbidity from transmission
- Room type: negative pressure otherwise through maternal exposure, the CDC
room is not required. o Fluid restriction (total fluids <75 does recommend the separation of
- If a patient has known cc/h) unless there is concern for mother and neonate.
COVID-19 or high suspicion sepsis or hemodynamic C Breastfeeding considerations
for it, PPE should be used per instability o Breast milk provision (by
hospital-specific guidelines. C CD pumping) is encouraged and is a
At a minimum, an N95 mask o Designate, when possible, 1 OR potentially important source of
and full droplet precaution for use for the suspected or antibodies for the infant. The
should be used by the pro- confirmed COVID-19 patient CDC recommends that during
viders in the room during the and have appropriate PPE temporary separation, women
second stage of labor. outside the OR door. who intend to breastfeed should
- Minimize change in providers. o A designated PPE monitor should be encouraged to express their
Depending on the volume of be assigned to ensure proper breast milk to establish and
COVID-19epositive patients, donning and doffing of PPE. maintain milk supply.
FIGURE 3
Flow chart for roles, equipment, and PPE in preparation for a cesarean delivery of COVID-positive patient
COVID, coronavirus disease; OB, obstetrician; OR, operating room; PPE, personal protective equipment; RN, registered nurse.
Boelig et al. Labor and delivery guidance for COVID-19. AJOG MFM 2020.
o Before expressing breast milk, recommends that if a woman and morbidity and as we have more
women should practice appro- newborn do room-in and the information regarding the asso-
priate hygiene not just for hands woman wishes to feed at the ciation between NSAIDs and
but also for breasts before breast, she should put on a mask COVID-19 severity.31
pumping. and practice hand hygiene before
o After pumping, all parts of the each feeding.41 Section 7: Care of the Critically Ill
pump that come in contact with C Pain control COVID-19 Pregnant Patient
breast milk should be thoroughly o The current FDA and WHO All critically ill COVID-19 patients
washed, and the entire pump guidelines are not to restrict should be in isolation as per hospital
should be appropriately dis- NSAID use. We support protocol. PPE equipment should be
infected per the manufacturer’s continued use of acetaminophen outside the patient’s room or unit if
instructions. and ibuprofen for pain control it is a dedicated COVID-19 unit.
o Expressed breast milk should be and do not suggest increased
fed to the newborn by a healthy narcotic use to replace ibuprofen Fetal well-being
caregiver. or NSAIDs. These general rec- C Corticosteroids: Given the poten-
o For women and infants who are ommendations may be modified tial risks of systemic steroids in
not separated, the CDC depending on patient-specific COVID-19, steroids for fetal
maturity should be used judi- o A hemorrhage kit, which in- C The use of a breast pump is
ciously, balancing the benefit by cludes Methergine, Hemabate, encouraged, after review of maternal
gestational age with potential risks and misoprostol, should be at medications (see Section 6). -
of worsening maternal morbidity. the bedside. Tranexamic acid
Decisions regarding the use of needs to be refrigerated but ACKNOWLEDGMENTS
corticosteroids for fetal lung should be requested for all de- We acknowledge the help of other members
maturity should be made in con- liveries and readily available in of the MFM Division and Ob-Gyn Department
cert with critical care team and the ICU. at the Thomas Jefferson University, including
neonatology. o The use of terbutaline should be Jason Baxter, Amanda Roman, Huda Al-
Kouatly, Rebekah McCurdy, Johanna Quist-
C For patients >24 weeks of preg- reviewed with the critical care
Nelson, Emily Rosenthal, Becca Pierce-
nancy, electronic fetal monitoring team, depending on the patient’s Williams, Leen Al-Hafez, Laura Felder,
for antenatal surveillance should be clinical status owing to risk of Lauren Johnson, Gina Gardigan, and William
performed at least daily and with tachycardia Schlaff.
any change in maternal status if a CD o An effective method of commu-
at bedside is feasible. The fetus can nication for the anesthesia team,
be a “sixth” vital sign reflecting early neonatology team and obstetric REFERENCES
deterioration in maternal status. team should be implemented. 1. Di Mascio D, Khalil A, Saccone G, et al.
C As per usual obstetric care, goal for o If an emergent delivery is plan- Outcome of coronavirus spectrum infections
(SARS, MERS, COVID-19) during pregnancy: a
saturations should be maintained ned, this should be performed at systematic review and meta-analysis. Am J
>95%. the bedside in the ICU to avoid Obstet Gynecol MFM 2020;2:100107.
transferring the patient. 2. The Society for Maternal-Fetal Medicine
Maternal medical care C Timing (SMFM), Dotters-Katz S, Hughes BL. Coronavi-
rus (COVID-19) and pregnancy: what maternal-
Special consideration should be given to o Consideration should be given to
fetal medicine subspecialists need to know.
normal maternal respiratory physiology delivery >34 weeks for the criti- Available at: https://s3.amazonaws.com/cdn.
and how this affects management of the cally ill pregnant patient. Delivery smfm.org/media/2267/COVID19-_updated_
acute respiratory distress syndrome can help optimize maternal res- 3-17-20_PDF.pdf. Accessed March 23, 2020.
(ARDS): piratory status. This should be 3. American College of Obstetricians & Gyne-
Pregnancy involves a natural respira- balanced with the potential risk cologists. Practice advisory. Novel coronavirus
2019 (COVID-19). Available at: https://www.
tory alkalosis with a normal PCO2 of 28 of catecholamine surge, auto- acog.org/clinical/clinical-guidance/practice-
to 32 mm Hg.42 transfusion, and fluid shifts that advisory/articles/2020/03/novel-coronavirus-2019.
Therapy for ARDS involves low tidal could potentially exacerbate Accessed March 23, 2020.
volumes and permissive hypercapnia maternal condition. 4. Royal College of Obstetricians & Gynaecolo-
(PCO2<60 mm Hg).43 Data on permis- C Intrapartum care gists. Coronavirus (COVID-19) infection in
pregnancy. Information for healthcare pro-
sive hypercapnia in pregnancy are o If a critically ill pregnant patient fessionals. Version 4: Available at: https://www.
limited, but there do not appear to be at term goes into labor, the rcog.org.uk/globalassets/documents/guidelines/
adverse fetal affects.44 aforementioned precautions 2020-03-21-covid19-pregnancy-guidance-
should be initiated. 2118.pdf. Published March 21, 2020.
C In the third trimester, increased o An assisted second stage of labor Accessed March 23, 2020.
5. World Health Organization. Clinical man-
positive end-expiratory pressures is likely to be necessary. agement of severe acute respiratory infection
may be required. o A dedicated obstetrician should when noval coronavirus (nCoV) infection is
C Goal for blood pressure should be be assigned to the patient with suspected. Interim guidance. Available at:
<160/110 mm Hg. minimal change in providers, as https://www.who.int/publications-detail/clinical-
C Patient should be positioned with left the situation allows. management-of-severe-acute-respiratory-infection-
when-novel-coronavirus-(ncov)-infection-is-
lateral tilt (if no other position is o The neonatology team should be suspected. Accessed March 23, 2020.
mandated for their treatment, eg, present at the time of delivery, 6. Boelig RC, Saccone G, Bellussi F,
prone position) to relieve pressure and the infant should be placed in Berghella V. MFM guidance for COVID-19. Am J
from gravid uterus on venous return. isolation after delivery, given the Obstet Gynecol MFM 2020;2:100106.
7. Daily Sabah. Coronavirus may affect two-
C Prone positioning may be used as unknown risks of transmission.
thirds of world population, specialist says.
necessary with appropriate support o Prevention of postpartum hem- Available at: https://www.dailysabah.com/
of gravid abdomen. orrhage should occur as detailed health/2020/02/13/coronavirus-may-affect-
above. two-thirds-of-world-population-specialist-says.
Delivery planning Accessed March 24, 2020.
C Preparation Postpartum care 8. Ma J, Lew L, Jeong-ho L. A third of coro-
navirus cases may be ‘silent carriers’, classi-
o Equipment for an emergent CD C The infant should be separated as fied Chinese data suggests. Available at:
should be available at the bedside, soon as possible and transferred to https://www.scmp.com/news/china/society/
including neonatal equipment. an isolation room appropriately. article/3076323/third-coronavirus-cases-may-